Nature of the immunogenic moiety recognized by the human T cell proliferating in response to trinitrophenyl-modified self-antigens.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002470:Cell Survival; D004303:Dosage Compensation, Genetic; D005802:Genes, MHC Class II; D006680:HLA Antigens; D006684:HLA-DR Antigens; D006801:Humans; D008213:Lymphocyte Activation; D009000:Monocytes / Q000276:immunology; D009578:Nitrobenzenes / Q000276:immunology*; D011817:Rabbits; D013601:T-Lymphocytes / Q000276:immunology*; D013745:Tetanus Toxoid / Q000276:immunology; D014301:Trinitrobenzenes / Q000276:immunology*; D014422:Turkeys
D000961:Antilymphocyte Serum; D006680:HLA Antigens; D006684:HLA-DR Antigens; D009578:Nitrobenzenes; D013745:Tetanus Toxoid; D014301:Trinitrobenzenes